Pharmacologic rationale for early G-CSF prophylaxis in cancer patients and role of pharmacogenetics in treatment optimization

F. Crea, E. Giovannetti, P.L. Zinzani, R. Danesi

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)21-44
JournalCritical Reviews in Oncology / Hematology
Volume72
Issue number1
DOIs
Publication statusPublished - 2009

Cite this

@article{c56073180a3141dd9fb91080a1f29625,
title = "Pharmacologic rationale for early G-CSF prophylaxis in cancer patients and role of pharmacogenetics in treatment optimization",
author = "F. Crea and E. Giovannetti and P.L. Zinzani and R. Danesi",
year = "2009",
doi = "10.1016/j.critrevonc.2008.10.014",
language = "Undefined/Unknown",
volume = "72",
pages = "21--44",
journal = "Critical Reviews in Oncology / Hematology",
issn = "1040-8428",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

Pharmacologic rationale for early G-CSF prophylaxis in cancer patients and role of pharmacogenetics in treatment optimization. / Crea, F.; Giovannetti, E.; Zinzani, P.L.; Danesi, R.

In: Critical Reviews in Oncology / Hematology, Vol. 72, No. 1, 2009, p. 21-44.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Pharmacologic rationale for early G-CSF prophylaxis in cancer patients and role of pharmacogenetics in treatment optimization

AU - Crea, F.

AU - Giovannetti, E.

AU - Zinzani, P.L.

AU - Danesi, R.

PY - 2009

Y1 - 2009

U2 - 10.1016/j.critrevonc.2008.10.014

DO - 10.1016/j.critrevonc.2008.10.014

M3 - Article

VL - 72

SP - 21

EP - 44

JO - Critical Reviews in Oncology / Hematology

JF - Critical Reviews in Oncology / Hematology

SN - 1040-8428

IS - 1

ER -